These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1393117)

  • 21. Risk of adverse events with fibrates.
    Alsheikh-Ali AA; Kuvin JT; Karas RH
    Am J Cardiol; 2004 Oct; 94(7):935-8. PubMed ID: 15464682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Potency disorders during the therapy or metabolic diseases].
    Overzier C
    Med Welt; 1977 Apr; 28(15):754. PubMed ID: 859432
    [No Abstract]   [Full Text] [Related]  

  • 23. Criteria for use of hypolipidemic agents in adults.
    Morales E; Spinler SA; Wilson MD; Chin MM; Jozefiak E
    Am J Hosp Pharm; 1994 Nov; 51(22):2837-41. PubMed ID: 7856612
    [No Abstract]   [Full Text] [Related]  

  • 24. [Gemfibrozil: new aspects in clinical use].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():625-30. PubMed ID: 11347143
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison between lovastatin and gemfibrozil in treatment of primary hyperlipidemias].
    Bertolami MC; Martinez TL; Faludi AA; Pinto LE; Melo RS; Bismarck ZF; Batlouni M
    Arq Bras Cardiol; 1991 May; 56(5):407-12. PubMed ID: 1823741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs for lipids.
    Treat Guidel Med Lett; 2014 Jan; 12(137):1-6; quiz 7-8. PubMed ID: 24419209
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease.
    Tonelli M; Collins D; Robins S; Bloomfield H; Curhan GC
    Am J Kidney Dis; 2004 Nov; 44(5):832-9. PubMed ID: 15492949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A long-term study on blood lipids after gemfibrozil].
    Lu Z
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):369-71. PubMed ID: 1821353
    [No Abstract]   [Full Text] [Related]  

  • 29. [Multicenter clinical, double blind, and randomized study to assess the effectiveness and safety of binifibrate versus gemfibrozil in type IIa, IIb, and IV hyperlipidemia].
    Corominas Vilardell A; de Oya Otero M; Escobar Jiménez F; Anguera Vila A; Ariño Armengol B
    An Med Interna; 1993 Nov; 10(11):537-41. PubMed ID: 8117868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gemfibrozil in hyperlipidaemia: an open, single blind trial.
    Varthakavi PK; Turakhia DP; Sharma SS; Salgaonkar DS; Nihalani KD; Joshi VR
    J Assoc Physicians India; 1990 Feb; 38(2):136-40. PubMed ID: 2380132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of gemfibrozil on serum apo C II and C III in diabetic hyperlipidemia].
    Tong N; Liang J
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):409-11. PubMed ID: 1814823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of gemfibrozil on serum lipids, lipoproteins and apolipoproteins in diabetes mellitus with dyslipidemia].
    Liang JZ; Li Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1988 Sep; 19(3):309-11. PubMed ID: 3253180
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyperlipidemia after renal transplantation: treatment with gemfibrozil.
    Chan TM; Cheng IK; Tam SC
    Nephron; 1994; 67(3):317-21. PubMed ID: 7936022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gemfibrozil in the treatment of hyperlipidemia].
    Wang JJ; Song YM; Wang YS; Lin WH
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Feb; 43(2):131-4. PubMed ID: 2766068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gemfibrozil-induced myopathy.
    Magarian GJ; Lucas LM; Colley C
    Arch Intern Med; 1991 Sep; 151(9):1873-4. PubMed ID: 1888257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gemfibrozil has antilipemic effects on diabetic patients with hyperlipidemia.
    Ho LT; Li SH; Chou TY; Liu YF; Perng JC; Han HK; Chen JJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Jan; 39(1):1-8. PubMed ID: 3484238
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study.
    Landry P; Dimitri E; Tessier S; Légaré N
    J Clin Psychopharmacol; 2008 Jun; 28(3):348-9. PubMed ID: 18480696
    [No Abstract]   [Full Text] [Related]  

  • 38. [Gemfibrozil in the treatment of lipid metabolism disorders].
    Vartanova OA; Aleksandrovskaia TN; Shaldaeva VV
    Klin Med (Mosk); 1994; 72(1):37-41. PubMed ID: 8196321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythema multiforme associated with gemfibrozil monotherapy.
    Yaçsar HY; Ertuğrul O; Deniz C
    Am J Med Sci; 2010 Jan; 339(1):86-8. PubMed ID: 20057279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hypolipidemic effect of gemfibrozil on hyperlipidemia in patients with non-insulin-dependent diabetes mellitus.
    Chang DM; Fuh MM; Jeng CY; Shian LR
    Taiwan Yi Xue Hui Za Zhi; 1986 May; 85(5):443-50. PubMed ID: 3463653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.